BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3001577)

  • 1. Naloxone reverses the effects of enalapril and enalaprilic acid on the pressor responses to afferent vagal stimulation.
    Montastruc P; Dang-Tran L; Carvajal A; Rostin M; Montastruc JL
    Neuropeptides; 1985 Dec; 6(6):537-42. PubMed ID: 3001577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of naloxone on the captopril-induced decrease in vagal pressor reflexes.
    Montastruc P; Montastruc JL; Gaillard-Plaza G
    J Pharmacol; 1984; 15(4):421-6. PubMed ID: 6396447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone suppresses the vasodepressor action of captopril in the anaesthetized dog.
    Montastruc JL; Gaillard-Plaza G; Montastruc P
    Clin Exp Hypertens A; 1984; 6(10-11):1825-8. PubMed ID: 6398140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation by naloxone of pressor reflexes.
    Montastruc JL; Montastruc P; Morales-Olivas F
    Br J Pharmacol; 1981 Sep; 74(1):105-9. PubMed ID: 7272594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure response to enalaprilic acid in essential hypertension: dose-response and effect of pre-treatment with furosemide.
    Navis GJ; de Jong PE; Donker AJ; van der Hem GK; de Zeeuw D
    Eur J Clin Pharmacol; 1985; 29(1):9-15. PubMed ID: 2996907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of spiraprilic acid, an angiotensin converting enzyme inhibitor, on large artery compliance in anesthetized dogs.
    Watkins RW; Sybertz EJ; Antonellis A; Pula K
    Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):222-34. PubMed ID: 2833190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension.
    Johnston CI; Jackson BJ; Larmour I; Cubella R; Casley D
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):233S-239S, 241S. PubMed ID: 6099738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition.
    Johnston CI; Jackson B; McGrath B; Matthews G; Arnolda L
    J Hypertens Suppl; 1983 Oct; 1(1):71-5. PubMed ID: 6100611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitors.
    Johnston CI; Jackson B; Cubela R; Larmour I; Arnolda L
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S9-14. PubMed ID: 2422495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man.
    Semple PF; Cumming AM; Meredith PA; Morton JJ
    Cardiovasc Drugs Ther; 1987; 1(1):45-50. PubMed ID: 2856460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.
    Ajayi AA; Hockings N; Reid JL
    Br J Clin Pharmacol; 1986 Apr; 21(4):349-57. PubMed ID: 3011047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of bromocriptine on the pressor responses to afferent nervous stimulation.
    Montastruc JL; Gaillard-Plaza G; Montastruc P
    J Pharmacol; 1984; 15(2):169-76. PubMed ID: 6738075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D; Navis GJ; Donker AJ; de Jong PE
    J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the intracerebroventricular injection of naloxone on the vagus-pressor response in rabbits].
    Chen JJ; Cui YY; Wang YH; Xie XM
    Sheng Li Xue Bao; 1985 Jun; 37(3):299-302. PubMed ID: 3834606
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effects of hemicholinum-3 and naloxone on the pressor response caused by central vagal stimulation].
    Wen XL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Aug; 4(4):234-7. PubMed ID: 6217912
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of naloxone on pressor responses to angiotensin II in anaesthetized greyhounds.
    Wilkinson DL; Scroop GC
    Clin Exp Pharmacol Physiol; 1986 Mar; 13(3):179-86. PubMed ID: 3720019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
    Reams GP; Lal SM; Whalen JJ; Bauer JH
    J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enalaprilat in hypertensive emergencies.
    Strauss R; Gavras I; Vlahakos D; Gavras H
    J Clin Pharmacol; 1986 Jan; 26(1):39-43. PubMed ID: 3005376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.